COMPANY NEWS


Caplin Point Laboratories Ltd
BSE Code 524742 ISIN Demat INE475E01026 Book Value (₹) 183.05 NSE Symbol CAPLIPOINT Div & Yield % 0.19 Market Cap ( Cr.) 9,984.82 P/E * 35.19 EPS * 37.36 Face Value (₹) 2
* Profit to Earning Ratio
* Earning Per Share
Caplin Point Laboratories receives INVIMA approval for Softgel Capsules division at Puducherry Back
(06 May 2024)
Caplin Point Laboratories has received Colombia's INVIMA approval for its Softgel Capsules division at Puducherry. The site inspection of Unit-1 was completed on 03 May and found compliant as per INVlMA's norms of Good Manufacturing Practices (GMP) and Good Laboratory Practices (GLP).